Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Gnanasakthy

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
JCO Oncology Practice|February 28, 2023
A Review of Patient-Reported Outcome Considerations in Oncologic Drugs Advisory Committee Meetings (2016-2021)Ari Gnanasakthy, Lindsey Norcross, Marci Clark, et al.
The Patient|July 20, 2011
Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyondMike Baldwin, Andrew Spong, Lynda Doward, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Considerations for Requiring Subjects to Provide a Response to Electronic Patient-Reported Outcome InstrumentsPaul O'Donohoe, J Jason Lundy, Ari Gnanasakthy, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Promotion of Patient-Reported Outcome Label Claims Based on Nonprimary EndpointsAri Gnanasakthy, Ashlyn Sadrick, Mariam Eghbal-Ahmadi, et al.
The Patient|September 18, 2016
Impact of Measuring Patient-Reported Outcomes in Dermatology Drug DevelopmentCatherine Copley-Merriman, Susan Zelt, Marci Clark, et al.
Neuropsychiatric Disease and Treatment|June 6, 2014
Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorderTheresa Coles, Cheryl Coon, Carla DeMuro, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and ComprehensibilityAri Gnanasakthy, Lindsey Norcross, Carla DeMuro Romano, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 6, 2023
A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, et al.
Health and Quality of Life Outcomes|March 7, 2014
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholdsVibeke Strand, Mark Kosinski, Ari Gnanasakthy, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System AgentsAri Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
JCO Oncology Practice|February 28, 2023
A Review of Patient-Reported Outcome Considerations in Oncologic Drugs Advisory Committee Meetings (2016-2021)Ari Gnanasakthy, Lindsey Norcross, Marci Clark, et al.
The Patient|July 20, 2011
Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyondMike Baldwin, Andrew Spong, Lynda Doward, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Considerations for Requiring Subjects to Provide a Response to Electronic Patient-Reported Outcome InstrumentsPaul O'Donohoe, J Jason Lundy, Ari Gnanasakthy, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Promotion of Patient-Reported Outcome Label Claims Based on Nonprimary EndpointsAri Gnanasakthy, Ashlyn Sadrick, Mariam Eghbal-Ahmadi, et al.
The Patient|September 18, 2016
Impact of Measuring Patient-Reported Outcomes in Dermatology Drug DevelopmentCatherine Copley-Merriman, Susan Zelt, Marci Clark, et al.
Neuropsychiatric Disease and Treatment|June 6, 2014
Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorderTheresa Coles, Cheryl Coon, Carla DeMuro, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and ComprehensibilityAri Gnanasakthy, Lindsey Norcross, Carla DeMuro Romano, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 6, 2023
A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, et al.
Health and Quality of Life Outcomes|March 7, 2014
Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholdsVibeke Strand, Mark Kosinski, Ari Gnanasakthy, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System AgentsAri Gnanasakthy, Carla DeMuro, Marci Clark, et al.
Pageof 6